Biotech

All Articles

Amgen files very first period 3 win for $400M chronic eczema drug

.Amgen has actually shared (PDF) the very first period 3 data on its $400 thousand eczema medication...

Biogen, UCB report period 3 lupus succeed after falling short earlier test

.Biogen and also UCB's bet one's bottom dollar developing in to stage 3 astride an unsuccessful rese...

Aptadir really hopes new RNA inhibitors can turn around complicated cancers cells

.Italian biotech Aptadir Rehabs has launched along with the guarantee that its own pipeline of precl...

Wave surfs DMD effectiveness to regulatory authorities' doors, delivering stock up

.Surge Lifestyle Sciences has met its target in a Duchenne muscular dystrophy (DMD) research study, ...

Sanofi plucks brand-new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, takin...

Achilles drops tissue treatment plan, bandages for unemployments after skipping 'business viability' goals

.Achilles Therapeutics has destroyed its own strategy. The English biotech is actually quiting worki...

Aligos proclaims stage 2 MASH succeed, slashing liver fat as much as 46%

.Aligos Therapeutics is actually trumpeting a midstage gain in metabolic-dysfunction affiliated stea...

Basilea ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work creating new antifungals has acquired a considerable increase coming f...

Capricor markets Europe rights to late-stage DMD treatment for $35M

.Possessing currently scooped up the USA civil liberties to Capricor Therapeutics' late-stage Duchen...

FDA scraps adcomm for Applied's rare condition medication

.After pushing the decision date for Applied Therapeutics' metabolic condition medication govorestat...